Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inspiration Biopharmaceuticals, Inc.

http://www.inspirationbio.com

Latest From Inspiration Biopharmaceuticals, Inc.

Transcatheter Systems Set To Dominate Heart Valve Market

Less invasive transcatheter techniques will increasingly displace older, riskier open-heart procedures in the treatment of heart valve disease, according to a new Meddevicetracker report. By 2021, transcatheter systems will account for 76% of the global market for heart valve disease treatment products, with the US retaining its current dominant position in this sector.

Medical Device Market Intelligence

Market Intel: Voyage Into Point-Of-Care Testing Gets Deeper

Diagnostic testing is increasingly moving from centralized laboratories into pharmacies, physicians' offices, hospitals and directly to consumers as part of the transition to value-based care with its focus on providing quality care at a lower cost. Point-of-care testing (POCT) – and what it means for the future of health-care delivery, health-care providers and creators of innovative technologies joining forces to satisfy consumers' growing appetite for convenient and rapid testing – took centerstage at the recent AACC Annual Meeting in San Diego. This feature takes a closer look at the increasing migration of POCT into the retail arena, specifically pharmacies, to support primary-care providers, along with its challenges. It also highlights emerging trends and technologies, including presentations of the "Star Trek-like" innovations from the Qualcomm Tricorder XPrize competition winners that are bound to disrupt the landscape of direct-to-consumer testing. We also provide expert opinions of the pros and cons of bringing POC services closer to consumers.

In Vitro Diagnostics Diagnostics

Aegerion CFO resigns

Aegerion Pharmaceuticals, a biopharmaceutical company developing innovative therapies for patients with rare diseases, has announced Mark Fitzpatrick, the company's chief financial officer, has resigned – effective 14 May 2015.

Companies

Ipsen goes back to black

French pharma company Ipsen has reported a return to profit in 2013 after putting behind it a costly venture in hemophilia which saw its partner Inspiration Biopharmaceuticals go bust and investigational candidate OBI-1 sold to Baxter International. Its outlook for 2014 was broadly welcomed by analysts as in line with expectations.

Gynecology & Urology Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register